Skip to main content
Top
Published in: Journal of Cardiovascular Magnetic Resonance 1/2018

Open Access 01-12-2018 | Research

Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein’s anomaly

Authors: Dan Yang, Xiao Li, Jia-Yu Sun, Wei Cheng, Andreas Greiser, Tian-Jing Zhang, Hong Liu, Ke Wan, Yong Luo, Qi An, Yiu-Cho Chung, Yuchi Han, Yu-Cheng Chen

Published in: Journal of Cardiovascular Magnetic Resonance | Issue 1/2018

Login to get access

Abstract

Background

Myocardial fibrosis is a common pathophysiological process that is related to ventricular remodeling in congenital heart disease. However, the presence, characteristics, and clinical significance of myocardial fibrosis in Ebstein’s anomaly have not been fully investigated. This study aimed to evaluate myocardial fibrosis using cardiovascular magnetic resonance (CMR) late gadolinium enhancement (LGE) and T1 mapping techniques, and to explore the significance of myocardial fibrosis in adolescent and adult patients with Ebstein’s anomaly.

Methods

Forty-four consecutive patients with unrepaired Ebstein’s anomaly (34.0 ± 16.2 years; 18 males), and an equal number of age- and gender-matched controls, were included. A comprehensive CMR protocol consisted of cine, LGE, and T1 mapping by modified Look-Locker inversion recovery (MOLLI) sequences were performed. Ventricular functional parameters, native T1, extracellular volume (ECV), and LGE were analyzed. Associations between myocardial fibrosis and disease severity, ventricular function, and NYHA classification were analyzed.

Results

LGE was found in 10 (22.7%) patients. Typical LGE in Ebstein’s anomaly was located in the endocardium of the septum within the right ventricle (RV). The LV ECV of Ebstein’s anomaly were significantly higher than those of the controls (30.0 ± 3.8% vs. 25.3 ± 2.3%, P < 0.001). An increased ECV was found to be independent of the existence of LGE. Positive LGE or higher ECV (≥30%) was associated with larger fRV volume, aRV volume, increased disease severity, and worse NYHA functional class. In addition, ECV was significantly correlated with the LV ejection fraction (P <  0.001).

Conclusions

Both focal and diffuse myocardial fibrosis were observed in adolescent and adult patients with Ebstein’s anomaly. Increased diffuse fibrosis is associated with worse LV function, increased Ebstein’s severity, and worse clinical status.
Literature
1.
go back to reference Tobler D, Yalonetsky S, Crean AM, Granton JT, Burchill L, Silversides CK, et al. Right heart characteristics and exercise parameters in adults with Ebstein anomaly: new perspectives from cardiac magnetic resonance imaging studies. Int J Cardiol. 2013;165:146–50.CrossRef Tobler D, Yalonetsky S, Crean AM, Granton JT, Burchill L, Silversides CK, et al. Right heart characteristics and exercise parameters in adults with Ebstein anomaly: new perspectives from cardiac magnetic resonance imaging studies. Int J Cardiol. 2013;165:146–50.CrossRef
2.
go back to reference Fratz S, Janello C, Muller D, Seligmann M, Meierhofer C, Schuster T, et al. The functional right ventricle and tricuspid regurgitation in Ebstein's anomaly. Int J Cardiol. 2013;167:258–61.CrossRef Fratz S, Janello C, Muller D, Seligmann M, Meierhofer C, Schuster T, et al. The functional right ventricle and tricuspid regurgitation in Ebstein's anomaly. Int J Cardiol. 2013;167:258–61.CrossRef
3.
go back to reference Attenhofer Jost CH. H.M.Connolly, W.D.Edwards, D H, Carole a.Warnes, G.K.Danielson. Ebstein’s anomaly – review of a multifaceted congenital cardiac condition. Swiss Med Wkly. 2005;165:269–81. Attenhofer Jost CH. H.M.Connolly, W.D.Edwards, D H, Carole a.Warnes, G.K.Danielson. Ebstein’s anomaly – review of a multifaceted congenital cardiac condition. Swiss Med Wkly. 2005;165:269–81.
4.
go back to reference Dearani JA, Mora BN, Nelson TJ, Haile DT, O'Leary PW. Ebstein anomaly review: what's now, what's next? Expert Rev Cardiovasc Ther. 2015;13:1101–9.CrossRef Dearani JA, Mora BN, Nelson TJ, Haile DT, O'Leary PW. Ebstein anomaly review: what's now, what's next? Expert Rev Cardiovasc Ther. 2015;13:1101–9.CrossRef
5.
go back to reference Lee CM, Sheehan FH, Bouzas B, Chen SS, Gatzoulis MA, Kilner PJ. The shape and function of the right ventricle in Ebstein's anomaly. Int J Cardiol. 2013;167:704–10.CrossRef Lee CM, Sheehan FH, Bouzas B, Chen SS, Gatzoulis MA, Kilner PJ. The shape and function of the right ventricle in Ebstein's anomaly. Int J Cardiol. 2013;167:704–10.CrossRef
6.
go back to reference Li X, Wang SM, Schreiber C, Cheng W, Lin K, Sun JY, et al. More than valve repair: effect of cone reconstruction on right ventricular geometry and function in patients with Ebstein anomaly. Int J Cardiol. 2016;206:131–7.CrossRef Li X, Wang SM, Schreiber C, Cheng W, Lin K, Sun JY, et al. More than valve repair: effect of cone reconstruction on right ventricular geometry and function in patients with Ebstein anomaly. Int J Cardiol. 2016;206:131–7.CrossRef
7.
go back to reference Goleski PJ, Sheehan FH, Chen SS, Kilner PJ, Gatzoulis MA. The shape and function of the left ventricle in Ebstein's anomaly. Int J Cardiol. 2014;171:404–12.CrossRef Goleski PJ, Sheehan FH, Chen SS, Kilner PJ, Gatzoulis MA. The shape and function of the left ventricle in Ebstein's anomaly. Int J Cardiol. 2014;171:404–12.CrossRef
8.
go back to reference Attenhofer Jost CH, Connolly HM, O'Leary PW, Warnes CA, Tajik AJ, Seward JB. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc. 2005;80:361–8.CrossRef Attenhofer Jost CH, Connolly HM, O'Leary PW, Warnes CA, Tajik AJ, Seward JB. Left heart lesions in patients with Ebstein anomaly. Mayo Clin Proc. 2005;80:361–8.CrossRef
9.
go back to reference Benson LN, Child JS, Schwaiger M, Perloff JK, Schelbert HR. Left ventricular geometry and function in adults with Ebstein's anomaly of the tricuspid valve. Circulation. 1987;75:353–9.CrossRef Benson LN, Child JS, Schwaiger M, Perloff JK, Schelbert HR. Left ventricular geometry and function in adults with Ebstein's anomaly of the tricuspid valve. Circulation. 1987;75:353–9.CrossRef
10.
go back to reference Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, et al. Effect of operation for Ebstein anomaly on left ventricular function. Am J Cardiol. 2008;102:1724–7.CrossRef Brown ML, Dearani JA, Danielson GK, Cetta F, Connolly HM, Warnes CA, et al. Effect of operation for Ebstein anomaly on left ventricular function. Am J Cardiol. 2008;102:1724–7.CrossRef
11.
go back to reference Celermajer DS, Dodd SM, Greenwald SE, Wyse RK, Deanfield JE. Morbid anatomy in neonates with Ebstein's anomaly of the tricuspid valve: pathophysiologic and clinical implications. J Am Coll Cardiol. 1992;19:1049–53.CrossRef Celermajer DS, Dodd SM, Greenwald SE, Wyse RK, Deanfield JE. Morbid anatomy in neonates with Ebstein's anomaly of the tricuspid valve: pathophysiologic and clinical implications. J Am Coll Cardiol. 1992;19:1049–53.CrossRef
12.
go back to reference Lee AH, Moore IE, Fagg NL, Cook AC, Kakadekar AP, Allan LD, et al. Histological changes in the left and right ventricle in hearts with Ebstein's malformation and tricuspid valvar dysplasia: a morphometric study of patients dying in the fetal and perinatal periods. Cardiovasc Pathol. 1995;4:19–24.CrossRef Lee AH, Moore IE, Fagg NL, Cook AC, Kakadekar AP, Allan LD, et al. Histological changes in the left and right ventricle in hearts with Ebstein's malformation and tricuspid valvar dysplasia: a morphometric study of patients dying in the fetal and perinatal periods. Cardiovasc Pathol. 1995;4:19–24.CrossRef
13.
go back to reference Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR working Group of the European Society of cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.CrossRef Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M, et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR working Group of the European Society of cardiology consensus statement. J Cardiovasc Magn Reson. 2013;15:92.CrossRef
14.
go back to reference aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16:210–6.CrossRef aus dem Siepen F, Buss SJ, Messroghli D, Andre F, Lossnitzer D, Seitz S, et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. Eur Heart J Cardiovasc Imaging. 2015;16:210–6.CrossRef
15.
go back to reference Beek AM, Bondarenko O, Afsharzada F, van Rossum AC. Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome. J Cardiovasc Magn Reson 2009;11:6.CrossRef Beek AM, Bondarenko O, Afsharzada F, van Rossum AC. Quantification of late gadolinium enhanced CMR in viability assessment in chronic ischemic heart disease: a comparison to functional outcome. J Cardiovasc Magn Reson 2009;11:6.CrossRef
16.
go back to reference Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, et al. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging. 2013;6:790–9.CrossRef Masci PG, Schuurman R, Andrea B, Ripoli A, Coceani M, Chiappino S, et al. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study. Circ Cardiovasc Imaging. 2013;6:790–9.CrossRef
17.
go back to reference Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging. 2016;9:1392–402.CrossRef Weng Z, Yao J, Chan RH, He J, Yang X, Zhou Y, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging. 2016;9:1392–402.CrossRef
18.
go back to reference Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015;132:1570–9.CrossRef Fontana M, Pica S, Reant P, Abdel-Gadir A, Treibel TA, Banypersad SM, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2015;132:1570–9.CrossRef
19.
go back to reference Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405–13.CrossRef Babu-Narayan SV, Kilner PJ, Li W, Moon JC, Goktekin O, Davlouros PA, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of fallot and its relationship to adverse markers of clinical outcome. Circulation. 2006;113:405–13.CrossRef
20.
go back to reference Broberg CS, Huang J, Hogberg I, McLarry J, Woods P, Burchill LJ, et al. Diffuse LV myocardial fibrosis and its clinical associations in adults with repaired tetralogy of Fallot. JACC Cardiovasc Imaging. 2016;9:86–7.CrossRef Broberg CS, Huang J, Hogberg I, McLarry J, Woods P, Burchill LJ, et al. Diffuse LV myocardial fibrosis and its clinical associations in adults with repaired tetralogy of Fallot. JACC Cardiovasc Imaging. 2016;9:86–7.CrossRef
21.
go back to reference Kozak MF, Redington A, Yoo SJ, Seed M, Greiser A, Grosse-Wortmann L. Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study. Pediatr Radiol. 2014;44:403–9.CrossRef Kozak MF, Redington A, Yoo SJ, Seed M, Greiser A, Grosse-Wortmann L. Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study. Pediatr Radiol. 2014;44:403–9.CrossRef
22.
go back to reference Carpentier A, Chauvaud S, Mace L, Relland J, Mihaileanu S, Marino JP, et al. A new reconstructive operation for Ebstein's anomaly of the tricuspid valve. J Thorac Cardiovasc Surg. 1988;96:92–101.PubMed Carpentier A, Chauvaud S, Mace L, Relland J, Mihaileanu S, Marino JP, et al. A new reconstructive operation for Ebstein's anomaly of the tricuspid valve. J Thorac Cardiovasc Surg. 1988;96:92–101.PubMed
23.
go back to reference Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson. 2013;15:51.CrossRef Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, et al. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson. 2013;15:51.CrossRef
24.
go back to reference Alfakih K, Reid S, Jones T, Sivananthan M. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol. 2004;14:1813–22.CrossRef Alfakih K, Reid S, Jones T, Sivananthan M. Assessment of ventricular function and mass by cardiac magnetic resonance imaging. Eur Radiol. 2004;14:1813–22.CrossRef
25.
go back to reference Yalonetsky S, Tobler D, Greutmann M, Crean AM, Wintersperger BJ, Nguyen ET, et al. Cardiac magnetic resonance imaging and the assessment of ebstein anomaly in adults. Am J Cardiol. 2011;107:767–73.CrossRef Yalonetsky S, Tobler D, Greutmann M, Crean AM, Wintersperger BJ, Nguyen ET, et al. Cardiac magnetic resonance imaging and the assessment of ebstein anomaly in adults. Am J Cardiol. 2011;107:767–73.CrossRef
26.
go back to reference White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging. 2013;6:955–62.CrossRef White SK, Sado DM, Fontana M, Banypersad SM, Maestrini V, Flett AS, et al. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging. 2013;6:955–62.CrossRef
27.
go back to reference Hosch O, Sohns JM, Nguyen TT, Lauerer P, Rosenberg C, Kowallick JT, et al. The total right/left-volume index: a new and simplified cardiac magnetic resonance measure to evaluate the severity of Ebstein anomaly of the tricuspid valve: a comparison with heart failure markers from various modalities. Circ Cardiovasc Imaging. 2014;7:601–9.CrossRef Hosch O, Sohns JM, Nguyen TT, Lauerer P, Rosenberg C, Kowallick JT, et al. The total right/left-volume index: a new and simplified cardiac magnetic resonance measure to evaluate the severity of Ebstein anomaly of the tricuspid valve: a comparison with heart failure markers from various modalities. Circ Cardiovasc Imaging. 2014;7:601–9.CrossRef
28.
go back to reference Josta CHA, Connolly HM, Edwards WD, Carole DH, Warnes A, Danielson GK. Ebstein’s anomaly – review of a multifaceted congenital cardiac condition. Swiss Med Wkly. 2005;165:269–81. Josta CHA, Connolly HM, Edwards WD, Carole DH, Warnes A, Danielson GK. Ebstein’s anomaly – review of a multifaceted congenital cardiac condition. Swiss Med Wkly. 2005;165:269–81.
29.
go back to reference Attie F, Rosas M, Rijlaarsdam M, Buendia A, Zabal C, Kuri J, et al. The adult patient with Ebstein anomaly. Outcome in 72 unoperated patients. Medicine (Baltimore). 2000;79:27–36.CrossRef Attie F, Rosas M, Rijlaarsdam M, Buendia A, Zabal C, Kuri J, et al. The adult patient with Ebstein anomaly. Outcome in 72 unoperated patients. Medicine (Baltimore). 2000;79:27–36.CrossRef
30.
go back to reference de Vette LC, Brugts JJ, McGhie JS, Roos-Hesselink JW. Long-lasting symptoms and diagnostics in a patient with unrecognized right sided heart failure: why listening to the heart is so important. World J Cardiol 2014;6:345–348.CrossRef de Vette LC, Brugts JJ, McGhie JS, Roos-Hesselink JW. Long-lasting symptoms and diagnostics in a patient with unrecognized right sided heart failure: why listening to the heart is so important. World J Cardiol 2014;6:345–348.CrossRef
31.
go back to reference Segura AM, Frazier OH, Buja LM. Fibrosis and heart failure. Heart Fail Rev. 2014;19:173–85.CrossRef Segura AM, Frazier OH, Buja LM. Fibrosis and heart failure. Heart Fail Rev. 2014;19:173–85.CrossRef
32.
go back to reference Chauvaud S, Berrebi A, d'Attellis N, Mousseaux E, Hernigou A, Carpentier A. Ebstein's anomaly: repair based on functional analysis. Eur J Cardiothorac Surg. 2003;23:525–31.CrossRef Chauvaud S, Berrebi A, d'Attellis N, Mousseaux E, Hernigou A, Carpentier A. Ebstein's anomaly: repair based on functional analysis. Eur J Cardiothorac Surg. 2003;23:525–31.CrossRef
33.
go back to reference Andrew HS, Lee M, Isabella E, Moore D, Nuala LK, Fagg M. histologic changes in the left and right ventrice in hearts withEebstein's malformation and tricuspid valvar dysplasia : a morphometric study of patients dying dying in the fatal and perinatal periods. Cardiovasc Pathol. 1995;4:19–24.CrossRef Andrew HS, Lee M, Isabella E, Moore D, Nuala LK, Fagg M. histologic changes in the left and right ventrice in hearts withEebstein's malformation and tricuspid valvar dysplasia : a morphometric study of patients dying dying in the fatal and perinatal periods. Cardiovasc Pathol. 1995;4:19–24.CrossRef
34.
go back to reference Frescura C, Angelini A, Daliento L, Thiene G. Morphological aspects of Ebstein's anomaly in adults. Thorac Cardiovasc Surg. 2000;48:203–8.CrossRef Frescura C, Angelini A, Daliento L, Thiene G. Morphological aspects of Ebstein's anomaly in adults. Thorac Cardiovasc Surg. 2000;48:203–8.CrossRef
35.
go back to reference Buturak A, Saygili O, Ulus S, Kalfa M, Karabulut H, Alhan C, et al. Right ventricular endomyocardial fibrosis mimicking Ebstein anomaly in a patient with Behcet's disease: case report and review of the literature. Mod Rheumatol. 2014;24:532–6.CrossRef Buturak A, Saygili O, Ulus S, Kalfa M, Karabulut H, Alhan C, et al. Right ventricular endomyocardial fibrosis mimicking Ebstein anomaly in a patient with Behcet's disease: case report and review of the literature. Mod Rheumatol. 2014;24:532–6.CrossRef
36.
go back to reference Balakrishnan KG, Sapru RP, Sasidharan K, Venkitachalam CG. A comparison of the clinical, haemodynamic and angiographic features in right ventricular endomyocardial fibrosis and Ebstein's anomaly of the tricuspid valve. Cardiology. 1982;69:265–75.CrossRef Balakrishnan KG, Sapru RP, Sasidharan K, Venkitachalam CG. A comparison of the clinical, haemodynamic and angiographic features in right ventricular endomyocardial fibrosis and Ebstein's anomaly of the tricuspid valve. Cardiology. 1982;69:265–75.CrossRef
37.
go back to reference Handa S, Fujii I, Ohonishi S, Yamazaki H, Nakamura Y. Strategy to manage pump failure due to chronic pulmonary diseases--pathophysiology and treatment of right ventricular overload. Jpn Circ J. 1986;50:350–8.CrossRef Handa S, Fujii I, Ohonishi S, Yamazaki H, Nakamura Y. Strategy to manage pump failure due to chronic pulmonary diseases--pathophysiology and treatment of right ventricular overload. Jpn Circ J. 1986;50:350–8.CrossRef
38.
go back to reference Chadwick RS, Azancot-Benisty A, Ohayon J, Ito Y. Right and left ventricle interaction and remodeling in congenital heart disease. Adv Exp Med Biol. 1993;346:373–81.CrossRef Chadwick RS, Azancot-Benisty A, Ohayon J, Ito Y. Right and left ventricle interaction and remodeling in congenital heart disease. Adv Exp Med Biol. 1993;346:373–81.CrossRef
39.
go back to reference Hong YJ, Park CH, Kim YJ, Hur J, Lee HJ, Hong SR, et al. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Int J Cardiovasc Imaging. 2015;31(Suppl 1):115–22.CrossRef Hong YJ, Park CH, Kim YJ, Hur J, Lee HJ, Hong SR, et al. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Int J Cardiovasc Imaging. 2015;31(Suppl 1):115–22.CrossRef
40.
go back to reference Attenhofer Jost CH, Connolly HM, Scott CG, Burkhart HM, Warnes CA, Dearani JA. Outcome of cardiac surgery in patients 50 years of age or older with Ebstein anomaly: survival and functional improvement. J Am Coll Cardiol. 2012;59:2101–6.CrossRef Attenhofer Jost CH, Connolly HM, Scott CG, Burkhart HM, Warnes CA, Dearani JA. Outcome of cardiac surgery in patients 50 years of age or older with Ebstein anomaly: survival and functional improvement. J Am Coll Cardiol. 2012;59:2101–6.CrossRef
41.
go back to reference Arya P, Beroukhim R. Ebstein anomaly: assessment, management, and timing of intervention. Curr Treat Options Cardiovasc Med. 2014;16:338.CrossRef Arya P, Beroukhim R. Ebstein anomaly: assessment, management, and timing of intervention. Curr Treat Options Cardiovasc Med. 2014;16:338.CrossRef
42.
go back to reference Dusenbery SM, Jerosch-Herold M, Rickers C, Colan SD, Geva T, Newburger JW, et al. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol. 2014;63:1778–85.CrossRef Dusenbery SM, Jerosch-Herold M, Rickers C, Colan SD, Geva T, Newburger JW, et al. Myocardial extracellular remodeling is associated with ventricular diastolic dysfunction in children and young adults with congenital aortic stenosis. J Am Coll Cardiol. 2014;63:1778–85.CrossRef
Metadata
Title
Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein’s anomaly
Authors
Dan Yang
Xiao Li
Jia-Yu Sun
Wei Cheng
Andreas Greiser
Tian-Jing Zhang
Hong Liu
Ke Wan
Yong Luo
Qi An
Yiu-Cho Chung
Yuchi Han
Yu-Cheng Chen
Publication date
01-12-2018
Publisher
BioMed Central
Published in
Journal of Cardiovascular Magnetic Resonance / Issue 1/2018
Electronic ISSN: 1532-429X
DOI
https://doi.org/10.1186/s12968-018-0488-1

Other articles of this Issue 1/2018

Journal of Cardiovascular Magnetic Resonance 1/2018 Go to the issue